Moermond CTA - Search Results

1

Reducing Pharmaceuticals in Water, a New Module Integrated in the Pharmacy Game: Evaluating the Module's Effects on Students' Knowledge and Attitudes.

Fens T, Moermond CTA, van der Maas P, Dantuma-Wering C, Lestestuiver GH, Szperl A, Schuiling LCM, Hak E, Taxis K. Fens T, et al. Among authors: moermond cta. Pharmacy (Basel). 2024 Feb 6;12(1):28. doi: 10.3390/pharmacy12010028. Pharmacy (Basel). 2024. PMID: 38392935 Free PMC article.

2

The Dutch chain approach on pharmaceuticals in water: Stakeholders acting together to reduce the environmental impact of pharmaceuticals.

Moermond CTA, de Rooy M. Moermond CTA, et al. Br J Clin Pharmacol. 2022 Dec;88(12):5074-5082. doi: 10.1111/bcp.15509. Epub 2022 Sep 14. Br J Clin Pharmacol. 2022. PMID: 36000992 Free PMC article.

3

GREENER Pharmaceuticals for More Sustainable Healthcare.

Moermond CTA, Puhlmann N, Brown AR, Owen SF, Ryan J, Snape J, Venhuis BJ, Kümmerer K. Moermond CTA, et al. Environ Sci Technol Lett. 2022 Sep 13;9(9):699-705. doi: 10.1021/acs.estlett.2c00446. Epub 2022 Aug 23. Environ Sci Technol Lett. 2022. PMID: 36118957 Free PMC article. Review.

4

Derivation of water quality standards for carbamazepine, metoprolol, and metformin and comparison with monitoring data.

Moermond CT, Smit CE. Moermond CT, et al. Environ Toxicol Chem. 2016 Apr;35(4):882-8. doi: 10.1002/etc.3178. Epub 2015 Dec 22. Environ Toxicol Chem. 2016. PMID: 26211655

5

CRED: Criteria for reporting and evaluating ecotoxicity data.

Moermond CT, Kase R, Korkaric M, Ågerstrand M. Moermond CT, et al. Environ Toxicol Chem. 2016 May;35(5):1297-309. doi: 10.1002/etc.3259. Epub 2016 Mar 18. Environ Toxicol Chem. 2016. PMID: 26399705

6

Prioritisation of data-poor pharmaceuticals for empirical testing and environmental risk assessment.

Cannata C, Backhaus T, Bramke I, Caraman M, Lombardo A, Whomsley R, Moermond CTA, Ragas AMJ. Cannata C, et al. Among authors: moermond cta. Environ Int. 2024 Jan;183:108379. doi: 10.1016/j.envint.2023.108379. Epub 2023 Dec 9. Environ Int. 2024. PMID: 38154319 Free article.

7

Improving the regulatory environmental risk assessment of human pharmaceuticals: Required changes in the new legislation.

Gildemeister D, Moermond CTA, Berg C, Bergstrom U, Bielská L, Evandri MG, Franceschin M, Kolar B, Montforts MHMM, Vaculik C. Gildemeister D, et al. Among authors: moermond cta. Regul Toxicol Pharmacol. 2023 Aug;142:105437. doi: 10.1016/j.yrtph.2023.105437. Epub 2023 Jun 22. Regul Toxicol Pharmacol. 2023. PMID: 37354938 Free article.

8

Proposal for regulatory risk mitigation measures for human pharmaceutical residues in the environment.

Moermond CTA, Berg C, Bergstrom U, Bielská L, Evandri MG, Franceschin M, Gildemeister D, Montforts MHMM. Moermond CTA, et al. Regul Toxicol Pharmacol. 2023 Sep;143:105443. doi: 10.1016/j.yrtph.2023.105443. Epub 2023 Jul 9. Regul Toxicol Pharmacol. 2023. PMID: 37433367 Free article.

9

An evaluation of bioaccumulation data for hexachlorobenzene to derive water quality standards according to the EU-WFD methodology.

Moermond CT, Verbruggen EM. Moermond CT, et al. Integr Environ Assess Manag. 2013 Jan;9(1):87-97. doi: 10.1002/ieam.1351. Epub 2012 Nov 7. Integr Environ Assess Manag. 2013. PMID: 22791265

10

PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.

Moermond CT, Janssen MP, de Knecht JA, Montforts MH, Peijnenburg WJ, Zweers PG, Sijm DT. Moermond CT, et al. Integr Environ Assess Manag. 2012 Apr;8(2):359-71. doi: 10.1002/ieam.1248. Epub 2012 Jan 6. Integr Environ Assess Manag. 2012. PMID: 22006646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page